REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmigene, Inc. (世基生物医学股份有限公司) (Taiwan, China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Pharmigene, Inc. Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Pharmigene, Inc. (世基生物医学股份有限公司) is a company in Taiwan, China, with a head office in Taipei City. It operates in the Medical Equipment and Supplies Manufacturing sector. It was first established on September 28, 2005. There are currently 41 (2023) people employed by Pharmigene, Inc. (世基生物医学股份有限公司). There was a net sales revenue increase of 68.23% reported in Pharmigene, Inc. (世基生物医学股份有限公司)’s latest financial highlights for Q2C2025. A negative growth of 5.91% was recorded in its total assets. Pharmigene, Inc. (世基生物医学股份有限公司)’s net profit margin increased by 50.29% in 2025.

Headquarters
4F., No. 17, Ln. 171, Sec. 2, Jiuzong Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Pharmigene, Inc. (世基生物医学股份有限公司) report to view the information.

Website: http://www.pharmigene.com.tw

Basic Information
Total Employees:
Purchase the Pharmigene, Inc. (世基生物医学股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Pharmigene, Inc. (世基生物医学股份有限公司) report to view the information.
Financial Auditors:
Purchase the Pharmigene, Inc. (世基生物医学股份有限公司) report to view the information.
Incorporation Date:
September 28, 2005
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Press Relations
Ownership Details
Purchase this report to view the information.
4.16%
Purchase this report to view the information.
3.37%
Purchase this report to view the information.
3.22%
Purchase this report to view the information.
2.36%
Purchase this report to view the information.
2.08%
Subsidiaries
Pharmigene Biomedical Pte.,Lid (Singapore)
100%
Pharmigene Inc (United States)
100%
Company Performance
Financial values in the chart are available after Pharmigene, Inc. (世基生物医学股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
68.23%
Total Operating Revenue
79.75%
Operating Profit
11.49%
EBITDA
54.16%
Net Profit/Loss for the Period
15.11%
Total Assets
-5.91%
Total Equity
-20.52%
Operating Profit Margin
40.19%
Net Profit Margin
50.29%
Return on Equity (ROE)
-0.85%
Debt / Equity
44772%
Quick Ratio
-3471.28%
Cash Ratio
-1.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?